If you live with diabetes, it is understandable to want a simple answer to the question, “What blood sugar should I aim for?”
For many adults, there are well-established treatment targets. However, I always remind my patients that these are general goals, not one-size-fits-all rules. Your safest target depends on your age, type and duration of diabetes, medicines, risk of hypoglycemia, pregnancy status, kidney or heart disease, and overall health.
The goal is not to keep glucose at one perfect number all day. It is to remain within a safe range as consistently as possible while avoiding prolonged high blood sugar and unnecessary low blood sugar.
For many nonpregnant adults with diabetes, commonly used treatment goals are:
| Measurement | Common target | What it means |
|---|---|---|
| Before meals | 80–130 mg/dL (4.4–7.2 mmol/L) |
A common premeal target for many nonpregnant adults |
| Peak after meals | Below 180 mg/dL (below 10.0 mmol/L) |
Usually assessed 1–2 hours after the beginning of the meal |
| A1C | Below 7% (below 53 mmol/mol) |
A common longer-term goal when it can be reached safely |
An acceptable blood glucose level is not necessarily the same as a “normal” glucose level in someone without diabetes.
When we set a diabetes target, we balance two priorities: keeping glucose low enough to reduce the risk of long-term complications while avoiding hypoglycemia and treatment that is too aggressive for the individual patient.
A single blood glucose reading does not provide a complete picture of diabetes control. In clinical practice, I consider the broader pattern, including fasting and premeal glucose levels, post-meal readings when appropriate, A1C, episodes of hypoglycemia, symptoms, current medications, and, when available, continuous glucose monitoring (CGM) data. These measures should also be interpreted in the context of established blood glucose and A1C ranges for normal glucose, prediabetes, and diabetes.
For many nonpregnant adults with diabetes, a common target before meals is 80–130 mg/dL (4.4–7.2 mmol/L).
This gives us useful information about your baseline glucose before food begins to raise it. If most of your premeal readings are within your agreed target, that is encouraging, but they should still be interpreted together with your post-meal pattern, A1C, low-glucose episodes and overall treatment plan.
A reading of 80 mg/dL is not hypoglycemia. It is near the lower end of the usual premeal target. Hypoglycemia is generally defined as glucose below 70 mg/dL.
If fasting or premeal readings are repeatedly above your personal target, possible contributors include overnight glucose production, meal or medication timing, illness, poor sleep, stress and changes in physical activity. A pattern over several days is more informative than one isolated morning reading.
If morning glucose is your main concern, see our guide to fasting blood sugar levels.
For many adults with diabetes, a common target is a peak post-meal glucose below 180 mg/dL (10.0 mmol/L).
When post-meal glucose is being assessed, it is generally measured 1–2 hours after the beginning of the meal. The timing matters because this period is intended to capture glucose near its post-meal peak.
One reading slightly above 180 mg/dL does not necessarily mean your treatment is failing. A larger meal, more carbohydrate than usual, illness, stress, poor sleep or reduced activity can all affect the result. More important questions are whether higher readings occur frequently, remain elevated for a long time, or appear alongside an A1C or CGM pattern showing excessive glucose exposure.
Because blood glucose changes throughout the day, the timing of a measurement matters, particularly when interpreting blood sugar levels after eating.
Daily readings show what your blood sugar is doing at a particular moment. A1C provides a broader view of glucose exposure over the previous two to three months, with more recent weeks contributing more to the result.
For many nonpregnant adults with diabetes, a common A1C goal is below 7% (53 mmol/mol) when it can be achieved safely. Some people may benefit from a lower goal. Others need a less stringent goal because hypoglycemia, frailty, serious comorbidities, cognitive or functional limitations, or treatment burden makes tighter control less safe.
I would not interpret A1C in isolation. Two people can have the same A1C while experiencing very different patterns of highs and lows.
Learn more in A1C vs Blood Sugar, or use our HbA1c to Average Glucose Calculator.
A continuous glucose monitor, or CGM, helps us look beyond individual fingerstick readings. It shows how much time glucose spends within, above and below the target range.
| CGM metric | Common goal for many adults |
|---|---|
| Time in range: 70–180 mg/dL | More than 70% of the time |
| Time below 70 mg/dL | Less than 4% of the time |
| Time below 54 mg/dL | Less than 1% of the time |
| Time above 180 mg/dL | Less than 25% of the time |
CGM goals also need to be individualized. Some older adults with complex health problems, for example, may need more permissive goals to reduce the risk of hypoglycemia.
There is no single bedtime glucose target appropriate for every adult with diabetes. Bedtime goals depend on insulin use, risk of overnight hypoglycemia, age, other medical conditions, recent exercise, meal timing and the treatment plan you follow.
If you use insulin or medicines that can cause hypoglycemia, your clinician may give you a specific bedtime target. Follow that individualized plan rather than relying on a universal bedtime number from the internet.
For people with diabetes, glucose below 70 mg/dL (3.9 mmol/L) is considered hypoglycemia and should be taken seriously. A level below 54 mg/dL (3.0 mmol/L) is more clinically significant.
Symptoms may include shakiness, sweating, hunger, palpitations, dizziness, weakness, irritability, confusion or difficulty concentrating. If you have a hypoglycemia treatment plan, follow it promptly. Frequent low readings require medical review because medication dose, meal timing or activity may need adjustment.
I would not give exactly the same glucose goal to every patient. Your targets may need to be individualized if you:
An older adult who is otherwise healthy may still have relatively tight glucose goals. Someone with frailty, several serious illnesses or recurrent hypoglycemia may need more relaxed targets because preventing low blood sugar becomes the greater priority.
Even when your treatment plan has not changed, glucose can vary from day to day. Common influences include:
This is why I encourage patients to look for patterns rather than reacting strongly to one unusual result.
Keeping glucose in range does not require perfect numbers every day. The practical goal is to make the overall pattern safer and more consistent. Depending on your treatment plan, helpful steps may include:
Do not change insulin or medication doses because of one unusual result unless your healthcare professional has given you a specific adjustment plan.
When a patient asks whether a blood sugar number is “acceptable,” I first ask when it was measured and what target we agreed on for that person.
A premeal glucose of 125 mg/dL may be within the usual target for many adults with diabetes. The same number means something different if we are discussing a fasting laboratory test used to screen a person who has not been diagnosed with diabetes.
I also do not judge diabetes control from one good reading or one bad reading. I want to know whether most values are reasonably close to target, whether there are repeated highs, whether low glucose is occurring, and whether the A1C or CGM report tells the same story.
The best target is not the lowest number you can achieve. It is the range that offers meaningful long-term protection while remaining safe and realistic for your health and treatment.
Contact your healthcare team if:
It depends on when it was measured. For many nonpregnant adults, 130 mg/dL is at the upper end of the common premeal target. After a meal, it may also be within an acceptable range, but your individual target may differ.
For many adults with diabetes, the common goal is a peak post-meal glucose below 180 mg/dL, assessed 1–2 hours after the beginning of the meal. Frequent readings at or above this level should be reviewed as a pattern.
Seventy mg/dL is the threshold at which we become concerned about hypoglycemia. A reading below 70 mg/dL should be treated according to your diabetes plan, and repeated lows should be discussed with your healthcare team.
No. Age, pregnancy, medications, hypoglycemia risk, kidney or heart disease, functional status and other health conditions can all affect the safest goal.
There is no universal bedtime target for every adult with diabetes. Your bedtime goal should reflect your treatment plan, especially if you use insulin or are at risk of overnight hypoglycemia.
No. Below 7% is a common goal for many nonpregnant adults, but some people may benefit from a lower goal and others need a less stringent one for safety.
For many nonpregnant adults with diabetes, common treatment goals are 80–130 mg/dL before meals, below 180 mg/dL at the peak after meals, and A1C below 7% when these goals can be achieved safely.
If you use CGM, spending more than 70% of the time between 70 and 180 mg/dL is a common goal for many adults, while time below 70 mg/dL should remain limited.
Most importantly, your target should fit you. A safe plan balances glucose control with your risk of hypoglycemia, medications, age, other medical conditions and daily life. I would rather see a patient follow a realistic, individualized target safely and consistently than chase a “perfect” number that creates unnecessary risk.
Medical disclaimer: This information is for general education and does not replace professional medical advice, diagnosis or treatment. Follow the glucose targets and treatment plan recommended by your healthcare professional. Do not change insulin or diabetes medication doses without appropriate medical guidance.
Written by: Dr. Albana Greca Sejdini, MD, MMedSc
Medically reviewed by: Dr. Ruden Cakoni, MD, Endocrinologist
Last medically reviewed: July 2026
Gestational diabetes usually causes no obvious symptoms, so blood testing is an important part of prenatal care. Most people who were not already found to have diabetes are screened between 24 and 28 weeks of pregnancy. Earlier testing may be recommended when there is a previous history of gestational diabetes, obesity, polycystic ovary syndrome, a strong family history, an earlier large baby, or another reason to suspect preexisting diabetes or high-risk abnormal glucose metabolism.
For most pregnancies without previously identified diabetes, screening is performed at 24–28 weeks. Insulin resistance normally increases during the second and third trimesters because placental hormones change how the body responds to insulin. This is why a normal early result does not always replace routine testing later in pregnancy.
Testing may occur earlier when the patient:
Risk-factor lists and screening policies vary by country. Some health systems screen all pregnant patients; others use risk-based early testing followed by routine testing at 24–28 weeks.
Testing early in pregnancy has two related goals:
The clinician may use fasting plasma glucose, HbA1c, random plasma glucose, or an early OGTT depending on the health system and clinical situation.
HbA1c is not the preferred stand-alone test for diagnosing gestational diabetes at 24–28 weeks. Pregnancy changes red-blood-cell turnover, and HbA1c does not show the same information as a glucose challenge or OGTT.
A normal early test may still need to be repeated at 24–28 weeks because pregnancy-related insulin resistance increases later.
This approach is commonly used in the United States.
The glucose challenge test is a screening test, not the final diagnostic test.
Clinics use different positive-screen thresholds, commonly 130, 135, or 140 mg/dL at one hour. A lower cutoff detects more possible cases but also sends more people for the diagnostic test.
A result above the clinic’s threshold means that a diagnostic OGTT is usually needed. It does not automatically mean that you have gestational diabetes.
After an overnight fast, blood is drawn before the drink and at one, two, and three hours after consuming 100 grams of glucose.
The commonly used Carpenter-Coustan thresholds are:
| 100-g OGTT time | Abnormal at or above | mmol/L equivalent |
|---|---|---|
| Fasting | 95 mg/dL | 5.3 mmol/L |
| 1 hour | 180 mg/dL | 10.0 mmol/L |
| 2 hours | 155 mg/dL | 8.6 mmol/L |
| 3 hours | 140 mg/dL | 7.8 mmol/L |
Under the traditional two-step method, gestational diabetes is generally diagnosed when two or more values meet or exceed the thresholds. One abnormal result may still be associated with increased pregnancy risk and may lead to nutrition counseling, repeat testing, home monitoring, or closer follow-up depending on the clinician.
The one-step strategy skips the separate 50-g screening test. After an overnight fast:
The commonly used IADPSG/ADA/WHO thresholds are:
| 75-g OGTT time | Gestational diabetes at or above | mmol/L equivalent |
|---|---|---|
| Fasting | 92 mg/dL | 5.1 mmol/L |
| 1 hour | 180 mg/dL | 10.0 mmol/L |
| 2 hours | 153 mg/dL | 8.5 mmol/L |
With this approach, one or more values meeting or exceeding the threshold establishes the diagnosis.
There is no single worldwide testing strategy. Different professional organizations and health systems may use:
The United Kingdom, for example, commonly uses a 75-g OGTT with different diagnostic criteria from the IADPSG/ADA one-step table.
The general adult “normal range” of 65–105 mg/dL should not be used to interpret all pregnancy test results. Each test has a specific glucose load, timing, and threshold.
They may identify concerning hyperglycemia, but they are not interchangeable with a standardized gestational diabetes protocol.
A fasting value may help identify preexisting diabetes or abnormal early-pregnancy glucose. It may also be one component of a 75-g or 100-g OGTT. A single fasting value does not replace the complete diagnostic test when the maternity protocol requires an OGTT.
A random test may be useful when symptoms or severe hyperglycemia are present. “Random” means the sample is taken without regard to the last meal; it does not mean blood is routinely drawn three times before, during, and after meals.
A glucose level two hours after an ordinary meal is useful for monitoring after diagnosis, but the meal does not contain a standardized amount of carbohydrate. It is not the same as an OGTT and should not be called the “second best” diagnostic test.
Glucose in urine is not accurate enough to diagnose or rule out gestational diabetes. Pregnancy changes the kidney threshold for glucose, so glycosuria can occur without gestational diabetes and gestational diabetes can occur without glycosuria.
Fasting is usually not required, but follow your clinic’s written instructions. Some clinics advise avoiding a very sugary meal immediately before testing.
The old instruction to consume at least 150 grams of carbohydrate for three days reflects older OGTT-preparation protocols. Some laboratories still provide carbohydrate guidance, while others advise the patient simply to maintain a normal unrestricted diet. Follow your laboratory’s protocol rather than a universal online rule.
Plan to remain at the laboratory for the entire testing period.
Tell the staff immediately if you vomit, feel faint, develop severe nausea, or cannot finish the drink. Vomiting may invalidate the test, but do not decide this yourself or leave without speaking to the staff.
Bring reading material, wear clothing that allows easy blood draws, and consider having someone accompany you if you have a history of fainting or severe nausea.
Temporary symptoms may include:
Most symptoms resolve after the test and a permitted meal. Ask the clinic when you may eat, drink, drive, and take morning medicines.
A standard glucose drink does not cause gestational diabetes. It temporarily challenges the body with a measured glucose amount so the response can be assessed.
After gastric bypass or another procedure associated with dumping syndrome, a standard glucose drink may cause severe symptoms and unreliable results. Some patients also cannot complete an OGTT because of recurrent vomiting or another medical condition.
There is no single universal substitute. The obstetric and diabetes teams may consider structured fasting and post-meal home glucose monitoring, continuous glucose monitoring, or another locally approved strategy. Do not substitute home readings without a documented clinical plan.
An abnormal diagnostic result means that pregnancy-related insulin resistance has exceeded the pancreas’s ability to maintain glucose below the selected thresholds.
It does not mean that:
It does mean that treatment and monitoring should begin promptly because managing glucose reduces pregnancy risks.
Possible risks of untreated or insufficiently controlled gestational diabetes include:
Most people with gestational diabetes can have a healthy pregnancy and baby with appropriate care.
These are treatment targets, not OGTT diagnostic thresholds.
| Home monitoring time | Common ADA target | mmol/L |
|---|---|---|
| Fasting | Below 95 mg/dL | Below 5.3 mmol/L |
| 1 hour after beginning a meal | Below 140 mg/dL | Below 7.8 mmol/L |
| 2 hours after beginning a meal | Below 120 mg/dL | Below 6.7 mmol/L |
Your maternity team may use different goals based on the pregnancy, glucose method, medication, fetal growth, and hypoglycemia risk.
A reading of 140 mg/dL has a different meaning when it is:
Always record the timing.
Care commonly includes:
Insulin is the preferred medicine in many guidelines when lifestyle measures are insufficient because it does not cross the placenta. Metformin is used in some health systems after individualized discussion, but it crosses the placenta and is not appropriate for every patient.
Do not start supplements, herbs, a ketogenic diet, prolonged fasting, or severe carbohydrate restriction to lower pregnancy glucose.
Read Gestational Diabetes Diet and Treatment Strategies and Tips for Controlling Gestational Diabetes.
Yes. Glucose often improves after delivery when placental hormones fall, but this should be confirmed.
ADA 2026 recommends:
The postpartum OGTT is preferred over HbA1c alone during the early postpartum period because blood loss, pregnancy-related changes in red-cell turnover, and iron status can affect HbA1c.
A history of gestational diabetes also increases the chance of recurrence in a later pregnancy. Tell future maternity teams early, even when postpartum glucose was normal.
Contact the maternity or diabetes team promptly for:
The 50-g screening test is usually nonfasting. Follow your clinic’s instructions because local protocols differ.
The clinic may use a cutoff of 130, 135, or 140 mg/dL. A value below its selected threshold usually means no diagnostic OGTT is needed unless there is another clinical concern.
No. It usually means the diagnostic 100-g OGTT is needed. Some clinics use a one-step 75-g strategy instead.
Water is commonly permitted, but confirm with the laboratory. Do not drink flavored, sweetened, or caloric beverages.
Usually no. Physical activity can change glucose handling. Remain seated or resting unless staff instructs otherwise.
Tell the staff immediately. The test may need to be stopped and repeated or replaced with another clinically approved strategy.
Not routinely at 24–28 weeks. HbA1c does not provide the same diagnostic information as a pregnancy OGTT.
Yes, although it is less common. Contact the maternity team if later fetal growth, symptoms, glucose readings, medicines, or another clinical finding raises concern.
Glucose often returns to normal, but not always. A postpartum 75-g OGTT is required to check for persistent diabetes or prediabetes.
Medical disclaimer: This page provides general education and cannot select your pregnancy screening method, diagnose gestational diabetes, or replace your obstetric or diabetes team. Follow the exact preparation instructions and diagnostic thresholds supplied by your maternity clinic and laboratory.